The December 2022 characterisation report, was the third report for the 2022-2023 influenza season. Currently, as of week 08/2023, 231 015 detections have been reported.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 March 2023 and includes updates on Marburg virus disease, iatrogenic botulism, COVID-19, Influenza, Group A streptococcal infection, cholera, poliomyelitis, measles, and extensively drug-resistant Pseudomonas aeruginosa.
Viral hepatitis is an inflammation of the liver caused by a virus. The most common hepatitis viruses in Europe are types A, B, and C (commonly referred to as HAV, HBV and HCV).
Influenza activity had been decreasing across the Region until week 4/2023, following a peak at week 51/2022, but has fluctuated around 25% since week 6/2023 due to increased type B virus circulation.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 5–11 March 2023 and includes updates on COVID-19, group A streptococcal infection, influenza, diphtheria, measles, iatrogenic botulism, poliomyelitis, and autochthonous Dengue.
Influenza activity had been decreasing across the Region until week 4/2023, following a peak at week 51/2022, but has fluctuated around 25% since week 6/2023 due to increased type B virus circulation.
Seasonal influenza activity had been decreasing across the Region after a peak at week 51/2022 until week 4/2023 and increased again up to week 7/2023 due to increased type B virus circulation.
This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 19-25 February 2023 and includes updates on the Earthquake in Türkiye and Syria, COVID-19, Influenza A (H5N1), Group A streptococcal infection, and cholera.